Understand the source comparison
Peptide Clinics Pennsylvania Providers Services 2026: Service Comparison
| Provider Type | Peptide Source | Regulatory Oversight | Typical Cost Range | COA/Purity Documentation | Clinical Oversight Model | Bottom Line ||—|—|—|—|—|—|| In-State Licensed Peptide Clinic | Research-grade suppliers (Real Peptides) or 503B compounders | P
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- | Provider Type | Peptide Source | Regulatory Oversight | Typical Cost Range | COA/Purity Documentation | Clinical Oversight Model | Bottom Line ||—|—|—|—|—|—|| In-State Licensed Peptide Clinic | Research-grade suppliers (Real Peptides) or 503B compounders | Pennsylvania Medical Board + State Pharmacy Board | $250–$600/month depending on peptide | Batch-specific HPLC purity reports provided | Initial telehealth consult + monthly follow-up | Best for patients seeking peptides unavailable as FDA-approved drugs (BPC-157, thymosin, Dihexa) with state-licensed oversight || National Telemedicine Platform | 503B compounding facilities (FDA-registered) | Multi-state compact + home state board | $300–$500/month (typically GLP-1 only) | Facility-level FDA registration, not batch COAs | Automated questionnaire + async messaging | Convenient for FDA shortage-approved compounded semaglutide/tirzepatide; limited peptide variety || Retail Pharmacy + Endocrinologist | FDA-approved peptide drugs only (